Drug Type Chemical drugs, Diagnostic radiopharmaceuticals |
Synonyms N-(4-Methoxy-13C-phenyl)acetamide |
Target- |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lung Injury | Phase 3 | US | 10 Jun 2016 | |
Chemical and Drug Induced Liver Injury | Phase 3 | US | 10 Jun 2016 | |
Liver Failure, Acute | Phase 3 | US | 10 Jun 2016 | |
Pulmonary Disease, Chronic Obstructive | Phase 3 | IL | 30 Sep 2010 | |
Hepatitis B, Chronic | Phase 3 | IL | 17 Sep 2010 | |
liver function failure | Phase 3 | US | 31 Mar 2010 | |
liver function failure | Phase 3 | IL | 31 Mar 2010 | |
Fibrosis | Phase 3 | US | 31 Aug 2008 | |
Fibrosis | Phase 3 | IL | 31 Aug 2008 | |
Complication | Phase 2 | US | 31 Mar 2015 |
Not Applicable | 124 | iiptlumgcv(mimnsmwgfj) = wjxrcdlrav vpfrsijpjw (bldcmvgcbq, pjaqsubopc - hevcbqolfl) View more | - | 09 Aug 2022 | |||
Phase 2/3 | 76 | owgiaxqqcr(jnqouokwqy) = quryyjvqah zwujdyxesv (qskcczlnnd, wnvujldivq - klhssrgnyp) View more | - | 22 Dec 2020 | |||
Not Applicable | 15 | 13C-methacetin | mmccrfdfcb(rkqslwlyvp) = vwjdpmgvrx rhnpvmtmnr (suhvvdbfjf, 753 - 61) | - | 27 Aug 2020 |